InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Sullivan Thomas Joseph, Directeur, Président et CEO. Insider active across 1 company, notably Natus Medical INC. Aggregated, 5 disclosures have been recorded. Activity tracked since 17 June 2021. The latest transaction was filed on 21 July 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations5 total
648,554 shares0Common Stock, $0.001 par value per shareSEC:0000878526-22-000090:0
52,084 shares@ US$24.0044.9% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-22-000004:0
52,084 shares@ US$24.0044.9% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-22-000004
5,214 shares@ US$28.775.1% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-21-000071
5,214 shares@ US$28.775.1% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-21-000071:0
5 of 5 declarations
About Sullivan Thomas Joseph
Thomas Joseph Sullivan is a Director, President and CEO at Natus Medical Inc. He is responsible for the strategic and operational direction of the company. Natus Medical is a provider of medical solutions for neonatal and neurological care. Thomas brings significant expertise in the healthcare sector, guiding the company toward achieving its goals.
